Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 246 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-RALOXIFENE | 60MG | TABLET | Resolved | 2020-06-24 | 2020-11-02 | 118772 |
APO-RASAGILINE | 1MG | TABLET | Resolved | 2020-06-24 | 2020-09-21 | 118775 |
APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2020-06-24 | 2020-08-17 | 118778 |
APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2020-06-24 | 2020-10-13 | 118781 |
APO-VARENICLINE | 0.5MG 1MG | KIT TABLET | Resolved | 2020-06-24 | 2020-08-10 | 118784 |
ANAFRANIL | 50MG | TABLET | Resolved | 2020-07-07 | 2020-09-03 | 119627 |
ALLERGY RELIEF | 10MG | TABLET | Resolved | 2020-07-08 | 2020-08-24 | 119673 |
APO-AMLODIPINE-ATORVASTATIN | 10MG 10MG | TABLET | Resolved | 2020-07-08 | 2020-07-13 | 119677 |
APO-AMLODIPINE-ATORVASTATIN | 10MG 40MG | TABLET | Resolved | 2020-07-08 | 2020-07-13 | 119683 |
APO-AMLODIPINE-ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2020-07-08 | 2020-07-13 | 119687 |
APO-AMLODIPINE-ATORVASTATIN | 5MG 80MG | TABLET | Resolved | 2020-07-08 | 2020-07-13 | 119690 |
APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2020-07-08 | 2020-07-24 | 119693 |
APO-CETIRIZINE | 10MG | TABLET | Resolved | 2020-07-08 | 2020-09-01 | 119696 |
APO-CITALOPRAM | 20MG | TABLET | Resolved | 2020-07-08 | 2020-09-01 | 119752 |
APO-DABIGATRAN | 75MG | CAPSULE | Resolved | 2020-07-08 | 2020-09-01 | 119756 |
APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-08 | 2020-07-18 | 119759 |
APO-OXYCODONE/ACET | 5MG 325MG | TABLET | Resolved | 2020-07-08 | 2020-09-21 | 119762 |
APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2020-07-08 | 2020-09-04 | 119765 |
APO-RIZATRIPTAN | 5MG | TABLET | Resolved | 2020-07-08 | 2020-08-21 | 119770 |
APO-WARFARIN | 5MG | TABLET | Resolved | 2020-07-08 | 2020-09-21 | 119773 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-08 | 60157 |
APO-AMOXI | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60246 |
APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
APO-ATENOL TAB 100MG | 100MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60261 |
APO-ATENOL TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60267 |
APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |
APO-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-11-09 | 60282 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |